Identification of the possible therapeutic targets in the insulin-like growth factor 1 receptor pathway in a cohort of Egyptian hepatocellular carcinoma complicating chronic hepatitis C type 4

Identification of the possible therapeutic targets in the insulin-like growth factor 1 receptor pathway in a cohort of Egyptian hepatocellular carcinoma complicating chronic hepatitis C type 4

Background: Molecular targeted drugs are the first line of treatment of advanced hepatocellular carcinoma (HCC) due to its chemo- and radioresistant nature. HCC has several well-documented etiologic factors that drive hepatocarcinogenesis through different molecular pathways. Currently, hepatitis C...

Full description

Bibliographic Details
Main Authors: Nada M.K. Mabrouk, Dalal M. Elkaffash, Mona Abdel-Hadi, Salah-ElDin Abdelmoneim, Sameh Saad ElDeen, Gihan Gewaifel, Khaled A. Elella, Maher Osman, Nahed Baddour
Format: Article
Language:English
Published: AboutScience Srl 2020-04-01
Series:Drug Target Insights
Subjects:
Gene expression
Hepatitis C virus
Hepatocellular carcinoma
Molecular therapeutic targets
Online Access:https://journals.aboutscience.eu/index.php/dti/article/view/1548

Similar Items

Similar Items